Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Berndt · SciRah

Researcher profile · Semantic Scholar

E. Berndt

Share profile

E. Berndt — researcher profile on SciRah

h-index: 62
Works: 262
Citations: 22K

Most-cited papers

Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers
M. Trusheim, E. Berndt, F. L. Douglas
2007Nature reviews. Drug discovery508 citations
Semantic Scholar
Trends in the globalization of clinical trials
Fabio A. Thiers, A. Sinskey, E. Berndt
2008Nature reviews. Drug discovery346 citations
Semantic Scholar
Prescription drug spending trends in the United States: looking beyond the turning point.
Murray L. Aitken, E. Berndt, David M. Cutler
2008Health Affairs160 citations
Semantic Scholar
The value of antihypertensive drugs: a perspective on medical innovation.
David M. Cutler, Genia Long, E. Berndt, Jimmy Royer +3 more
2007Health Affairs130 citations
Semantic Scholar
Authorized generic drugs, price competition, and consumers' welfare.
E. Berndt, Richard Mortimer, A. Bhattacharjya, A. Parece +1 more
2007Health Affairs116 citations
Semantic Scholar
Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness.
E. Berndt, R. Glennerster, M. Kremer, J. Lee +3 more
2007Health Economics115 citations Open access
Semantic Scholar
Quantifying factors for the success of stratified medicine
M. Trusheim, B. Burgess, S. Hu, Theresa W. Long +11 more
2011Nature reviews. Drug discovery103 citations
Semantic Scholar
Decline in economic returns from new drugs raises questions about sustaining innovations.
E. Berndt, D. Nass, Michael Kleinrock, Murray L. Aitken
2015Health Affairs74 citations
Semantic Scholar
Economic perspectives on the advance market commitment for pneumococcal vaccines.
Christopher M. Snyder, Wills Begor, E. Berndt
2011Health Affairs63 citations
Semantic Scholar
Generic Entry, Reformulations and Promotion of SSRIs in the US
H. Huskamp, J. Donohue, Catherine Koss, E. Berndt +1 more
2012PharmacoEconomics (Auckland)58 citations Open access
Semantic Scholar
of Productivity and Performance Management Objective and self-report work performance measures : a comparative analysis
G. Pransky, S. Finkelstein, E. Berndt, M. Kyle +2 more
201657 citations
Semantic Scholar
Title : Hard-to-Measure Goods and Services : Essays in Honor of Zvi Griliches
E. Berndt, C. Hulten, D. Jorgenson, P. Schreyer
200749 citations
Semantic Scholar
A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets
E. Berndt, T. Mcguire, J. Newhouse
201145 citations Open access
Semantic Scholar
The hidden cost of low prices: limited access to new drugs in India.
E. Berndt, I. Cockburn
2014Health Affairs41 citations
Semantic Scholar
Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?
M. Trusheim, Murray L. Aitken, E. Berndt
201040 citations Open access
Semantic Scholar
Has The Era Of Slow Growth For Prescription Drug Spending Ended?
Murray L. Aitken, E. Berndt, David M. Cutler, Michael Kleinrock +1 more
2016Health Affairs35 citations Open access
Semantic Scholar
The heterogeneity of concentrated prescribing behavior: Theory and evidence from antipsychotics.
E. Berndt, Robert S Gibbons, A. Kolotilin, A. Taub
2015Journal of Health Economics35 citations
Semantic Scholar
Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts
Tomas J. Philipson, E. Berndt, Adrian H. B. Gottschalk, Eric C. Sun
200835 citations Open access
Semantic Scholar
Introduction to "Hard-to-Measure Goods and Services: Essays in Honor of Zvi Griliches"
E. Berndt, C. Hulten
200735 citations
Semantic Scholar
Rates of Return and Capital Aggregation, Using Alternative Rental Prices
M. Harper, E. Berndt, D. Wood
201534 citations
Semantic Scholar
The net value of health care for patients with type 2 diabetes, 1997 to 2005.
K. Eggleston, N. Shah, Steven A. Smith, A. Wagie +6 more
2009Annals of Internal Medicine30 citations
Semantic Scholar
Biosimilars And Follow-On Products In The United States: Adoption, Prices, And Users.
A. Stern, Jacqueline L Chen, Melissa Ouellet, M. Trusheim +3 more
2021Health Affairs29 citations
Semantic Scholar
Reductions in anaemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy
E. Berndt, J. Kallich, A. Mcdermott, Xiao Xu +2 more
2012PharmacoEconomics (Auckland)29 citations
Semantic Scholar
Dynamic Competition in Pharmaceuticals: Cross-National Evidence from New Drug Diffusion
E. Berndt, P. Danzon, G. Kruse
200728 citations
Semantic Scholar
Short run labor productivity in a dynamic model
C. Morrison, E. Berndt
201526 citations Open access
Semantic Scholar
The generic drug user fee amendments: an economic perspective
E. Berndt, R. Conti, Stephen J. Murphy
2018Journal of Law and the Biosciences25 citations Open access
Semantic Scholar
Investigating investment in biopharmaceutical R&D
P. Carter, E. Berndt, J. DiMasi, M. Trusheim
2016Nature reviews. Drug discovery19 citations Open access
Semantic Scholar
Depression treatment: a lifelong commitment?
M. Keller, E. Berndt
2015Psychopharmacology bulletin19 citations
Semantic Scholar
The clinical benefits, ethics, and economics of stratified medicine and companion diagnostics.
M. Trusheim, E. Berndt
2015Drug Discovery Today18 citations
Semantic Scholar
Patterns of Physician Antipsychotic Prescribing to Young Children
H. Huskamp, M. Horvitz-Lennon, E. Berndt, S. Normand +1 more
2016Psychiatric Services17 citations Open access
Semantic Scholar
Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug Development
L. G. Baird, M. Trusheim, H. Eichler, E. Berndt +1 more
2013Therapeutic Innovation and Regulatory Science17 citations
Semantic Scholar
Pharmaceutical Innovation: The United States' Experience with Direct-to-Consumer Advertising of Prescription Drugs: What Have We Learned?
E. Berndt
200717 citations
Semantic Scholar
The impact of anaemia and its treatment on employee disability and medical costs
E. Berndt, W. Crown, J. Kallich, S. Long +2 more
2012PharmacoEconomics (Auckland)16 citations
Semantic Scholar
Economic challenges and possible policy actions to advance stratified medicine.
M. Trusheim, E. Berndt
2012Personalized Medicine15 citations
Semantic Scholar
Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999–2009.
K. Eggleston, N. Shah, Steven A. Smith, E. Berndt +1 more
2011The American Economic Review15 citations Open access
Semantic Scholar
The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines
R. Frank, Andrew L Hicks, E. Berndt
2019Medical Care Research and Review14 citations Open access
Semantic Scholar
The geography of prescription pharmaceuticals supplied to the USA: levels, trends, and implications
Yashna Shivdasani, Neriman Beste Kaygisiz, E. Berndt, R. Conti
2021Journal of Law and the Biosciences13 citations Open access
Semantic Scholar
FOUR FACTS CONCERNING COMPETITION IN U.S. GENERIC PRESCRIPTION DRUG MARKETS
R. Conti, E. Berndt
2019International Journal of Economic and Business13 citations Open access
Semantic Scholar
Uncertain prognosis for high-quality diagnostics: clinical challenges, economic barriers and needed reforms.
M. Trusheim, M. J. Finley Austin, Carsten Rausch, E. Berndt
2013Pharmacogenomics (London)13 citations
Semantic Scholar
Diffusion of New Drugs in the Post-TRIPS Era
E. Berndt, Nathan Blalock, I. Cockburn
201113 citations
Semantic Scholar
Regional variation in physician adoption of antipsychotics: Impact on US Medicare expenditures
J. Donohue, S. Normand, M. Horvitz-Lennon, A. Men +2 more
2016Journal of Mental Health Policy and Economics12 citations
Semantic Scholar
THE IMPACT OF EMERGING SAFETY AND EFFECTIVENESS EVIDENCE ON THE USE OF PHYSICIAN-ADMINISTERED DRUGS: THE CASE OF BEVACIZUMAB FOR BREAST CANCER
R. Conti, S. Dusetzina, Ann C Herbert, E. Berndt +2 more
2013Medical Care10 citations Open access
Semantic Scholar
The Unbundling of Advertising Agency Services: An Economic Analysis
Mohammad Arzaghi, E. Berndt, James C. Davis, A. Silk
201210 citations
Semantic Scholar
Characterization of annual disease progression of multiple sclerosis patients: A population-based study
J. Freilich, A. Manouchehrinia, M. Trusheim, L. G. Baird +3 more
2018Multiple Sclerosis9 citations Open access
Semantic Scholar
Measuring and Modeling Health Care Costs
Ana M. Aizcorbe, C. Baker, E. Berndt, David M. Cutler
20189 citations
Semantic Scholar
Market watch: Defining and quantifying the use of personalized medicines
S. Hu, Murray L. Aitken, A. Epstein, M. Trusheim +1 more
2013Nature reviews. Drug discovery9 citations
Semantic Scholar
Residential Electricity Demand in Mexico: A Model Distinguishing Access From Consumption
E. Berndt, Ricardo Samaniego
20188 citations Open access
Semantic Scholar
Antipsychotic prescribing: Do conflict of interest policies make a difference?
T. Anderson, H. Huskamp, A. Epstein, Colleen L. Barry +5 more
2015Medical Care8 citations Open access
Semantic Scholar
Radiologist productivity: what, why, and how.
Alexander Ding, S. Saini, E. Berndt
2009Journal of the American College of Radiology8 citations
Semantic Scholar
Hard-to-Measure Goods and Services
E. Berndt, C. Hulten
20078 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Trusheim×11
Invite
M. Trusheim — researcher profile on SciRah
Murray L. Aitken×5
Invite
Murray L. Aitken — researcher profile on SciRah
H. Huskamp×5
Invite
H. Huskamp — researcher profile on SciRah
David M. Cutler×4
Invite
David M. Cutler — researcher profile on SciRah

×4

Invite

J. Donohue — researcher profile on SciRah

Invite

R. Conti — researcher profile on SciRah

Invite

C. Hulten — researcher profile on SciRah

Invite

J. Newhouse — researcher profile on SciRah

M. Horvitz-Lennon×3

Invite

M. Horvitz-Lennon — researcher profile on SciRah

Invite

S. Normand — researcher profile on SciRah

Invite

S. Hu — researcher profile on SciRah

Michael Kleinrock×2

Invite

Michael Kleinrock — researcher profile on SciRah